Atlas Trials

Glecaprevir/Pibrentasvir Real-world Study in China

Clinical trial NCT03941821 · UNKNOWN

Trial details

NCT number
NCT03941821
Sponsor
Tongji Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Chronic Hepatitis c
Start date
2019-06-30
Primary completion
2021-06-30
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.